PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Public ClinicalTrials.gov record NCT00690066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to establish the safety and efficacy of multiple administrations of PROCHYMAL® in participants recently diagnosed with type 1 diabetes mellitus.
Study identification
- NCT ID
- NCT00690066
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 11, 2008 (Actual)
- Primary completion
- Dec 12, 2010 (Actual)
- Completion
- Dec 19, 2011 (Actual)
- Last update posted
- Mar 11, 2026
2008 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama, Division of Endocrinology & Metabolism | Birmingham | Alabama | 35294 | — |
| Scripps Whittier Diabetes Institute | La Jolla | California | 92037 | — |
| Stanford University | Stanford | California | 94305 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Diabetes Research Institute | Miami | Florida | 33136 | — |
| University of Kentucky | Lexington | Kentucky | 40502 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Desert Endocrinology CRC | Henderson | Nevada | 89052 | — |
| Nevada Alliance Against Diabetes | Las Vegas | Nevada | 89101 | — |
| University of North Carolina Diabetes Care Center | Chapel Hill | North Carolina | 27599 | — |
| American Health Research, Inc. | Charlotte | North Carolina | 28207 | — |
| The Lindner Clinical Trial Center | Cincinnati | Ohio | 45219 | — |
| Providence Health Partners - Center for Clinical Research | Dayton | Ohio | 45439 | — |
| Cumberland Valley Endocrinology | Carlisle | Pennsylvania | 17015 | — |
| AM Diabetes & Endocrinology Center | Bartlett | Tennessee | 38133 | — |
| The University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Optimum Clinical Research, Inc. | Salt Lake City | Utah | 84102 | — |
| The Strelitz Diabetes Center, Eastern VA Medical School | Norfolk | Virginia | 23510 | — |
| University of Wisconsin Health- West Clinic | Madison | Wisconsin | 53717 | — |
| Clinical and Transitional Science Institute | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00690066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00690066 live on ClinicalTrials.gov.